Vun-Sin Lim, Managing Editor of the Journal of Thoracic Oncology, shared a post on LinkedIn:
“June JTO Editor’s Picks. See links to articles and accompanying editorials in comments.
- JTO 20th Anniversary Series: Advances in Diagnosis-Pulmonology – Stone E et al.
- Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose Computed Tomography Lung Cancer Screening – Zanghì A et al.
- Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee – McMahon RA et al.
- Identifying Patients With High-Risk Stage I NSCLC Using a Tumor-Informed Plasma ctDNA Assay – Feng J et al.”
High PD-L1 Expression Linked To Shorter PFS With First-Line ALK TKIs In ALK-Rearranged NSCLC
